Atlas Trials

The Effect of Moxonidine on Blood Pressure and Regression of Early Target Organ Damage in Young Subjects With Abdominal Obesity and Hypertension

Clinical trial NCT01360710 · UNKNOWN

Trial details

NCT number
NCT01360710
Sponsor
Baker Heart and Diabetes Institute
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Abdominal ObesityHypertension
Start date
2012-01-01
Primary completion
2014-01-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.